AAPL vs JNJ: Which Is the Better Buy?
Side-by-side comparison of Apple Inc. and Johnson & Johnson — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Apple Inc. · Technology
$337.02
+9.9% upside to fair value
Med Conviction
Grade B
High Quality
VS
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
AAPL has more upside to fair value
(+9.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AAPL |
JNJ |
| Current Price |
$337.02 |
$270.68 |
| Fair Value Estimate |
$370.54 |
$286.05 |
| Upside to Fair Value |
+9.9%
|
+5.7%
|
| Market Cap |
$4,949.9B |
$652.3B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
29.6x
|
20.2x
|
| Price / Sales |
10.6x
|
6.7x
|
| Price / FCF |
36.2x
|
35.3x
|
| Revenue Growth YoY |
+16.4%
|
+6.6%
|
| Gross Margin |
48.7%
|
67.9%
|
| Operating Margin |
33.2%
|
26.8%
|
| Return on Equity |
137.2%
|
25.7%
|
| Dividend Yield |
0.31% |
1.95% |
| FCF Yield |
2.76%
|
2.83%
|
| Analyst Consensus |
Buy
|
Buy
|
Investment Thesis
Apple Inc. is a global consumer-electronics and services platform whose hardware lineup (iPhone, Mac, iPad, wearables) and digital ecosystem (App Store, Apple Music, iCloud, Apple Pay, advertising) generated $31.78 of revenue per share and $9.30 of free cash flow per share on a trailing basis, with TTM gross margin of 48.7%, operating margin of 33.2%, net margin of 27.6%, and ROE of 137.2%. Busin…
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
Accumulation Zones
| Metric |
AAPL |
JNJ |
| Zone Low |
$277.91 |
$214.54 |
| Zone High |
$314.96 |
$243.14 |
| In Buy Zone? |
No
|
No
|